top of page

2021 WHO Optimal Formulary and Limited-Use List for ARVs for Children

Updated: Oct 14, 2021

This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for infants and children, while giving due consideration to the rapidly evolving treatment landscape and the risks inherent in the uncertain timelines for pediatric drug development.

Related Posts

See All
bottom of page